Nevertheless, both groups reported a progressive stabilization or improvement in ILD anti-Ro associated [36, 37], as reported in our cohort, where anti-Ro-52 is the only serological marker of functional tests’ improvement at 1 and 5 years after ILD onset. Here, CALR is linked to interstitial lung disease.